1 Market Overview
1.1 Product Overview and Scope of Integrin Alpha V
1.2 Classification of Integrin Alpha V by Type
1.2.1 Overview: Global Integrin Alpha V Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Integrin Alpha V Revenue Market Share by Type in 2020
1.2.3 MK-0429
1.2.4 C-16Y
1.2.5 264-RAD
1.2.6 AC-301
1.2.7 Others
1.3 Global Integrin Alpha V Market by Application
1.3.1 Overview: Global Integrin Alpha V Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Metabolic Disorders
1.3.3 Ophthalmology
1.3.4 Respiratory
1.3.5 Infectious Disease
1.3.6 Others
1.4 Global Integrin Alpha V Market Size & Forecast
1.5 Global Integrin Alpha V Market Size and Forecast by Region
1.5.1 Global Integrin Alpha V Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Integrin Alpha V Market Size by Region, (2016-2021)
1.5.3 North America Integrin Alpha V Market Size and Prospect (2016-2026)
1.5.4 Europe Integrin Alpha V Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Integrin Alpha V Market Size and Prospect (2016-2026)
1.5.6 South America Integrin Alpha V Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Integrin Alpha V Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Integrin Alpha V Market Drivers
1.6.2 Integrin Alpha V Market Restraints
1.6.3 Integrin Alpha V Trends Analysis
2 Company Profiles
2.1 Biogen Inc
2.1.1 Biogen Inc Details
2.1.2 Biogen Inc Major Business
2.1.3 Biogen Inc Integrin Alpha V Product and Solutions
2.1.4 Biogen Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Biogen Inc Recent Developments and Future Plans
2.2 BioMAS Ltd
2.2.1 BioMAS Ltd Details
2.2.2 BioMAS Ltd Major Business
2.2.3 BioMAS Ltd Integrin Alpha V Product and Solutions
2.2.4 BioMAS Ltd Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioMAS Ltd Recent Developments and Future Plans
2.3 Factor Therapeutics Ltd
2.3.1 Factor Therapeutics Ltd Details
2.3.2 Factor Therapeutics Ltd Major Business
2.3.3 Factor Therapeutics Ltd Integrin Alpha V Product and Solutions
2.3.4 Factor Therapeutics Ltd Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Factor Therapeutics Ltd Recent Developments and Future Plans
2.4 MedImmune LLC
2.4.1 MedImmune LLC Details
2.4.2 MedImmune LLC Major Business
2.4.3 MedImmune LLC Integrin Alpha V Product and Solutions
2.4.4 MedImmune LLC Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 MedImmune LLC Recent Developments and Future Plans
2.5 Merck & Co Inc
2.5.1 Merck & Co Inc Details
2.5.2 Merck & Co Inc Major Business
2.5.3 Merck & Co Inc Integrin Alpha V Product and Solutions
2.5.4 Merck & Co Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merck & Co Inc Recent Developments and Future Plans
2.6 Merck KGaA
2.6.1 Merck KGaA Details
2.6.2 Merck KGaA Major Business
2.6.3 Merck KGaA Integrin Alpha V Product and Solutions
2.6.4 Merck KGaA Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck KGaA Recent Developments and Future Plans
2.7 Morphic Therapeutic Inc
2.7.1 Morphic Therapeutic Inc Details
2.7.2 Morphic Therapeutic Inc Major Business
2.7.3 Morphic Therapeutic Inc Integrin Alpha V Product and Solutions
2.7.4 Morphic Therapeutic Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Morphic Therapeutic Inc Recent Developments and Future Plans
2.8 SciFluor Life Sciences LLC
2.8.1 SciFluor Life Sciences LLC Details
2.8.2 SciFluor Life Sciences LLC Major Business
2.8.3 SciFluor Life Sciences LLC Integrin Alpha V Product and Solutions
2.8.4 SciFluor Life Sciences LLC Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 SciFluor Life Sciences LLC Recent Developments and Future Plans
2.9 Vascular Pharmaceuticals Inc
2.9.1 Vascular Pharmaceuticals Inc Details
2.9.2 Vascular Pharmaceuticals Inc Major Business
2.9.3 Vascular Pharmaceuticals Inc Integrin Alpha V Product and Solutions
2.9.4 Vascular Pharmaceuticals Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Vascular Pharmaceuticals Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Integrin Alpha V Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Integrin Alpha V Players Market Share
3.2.2 Top 10 Integrin Alpha V Players Market Share
3.2.3 Market Competition Trend
3.3 Integrin Alpha V Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Integrin Alpha V Revenue and Market Share by Type (2016-2021)
4.2 Global Integrin Alpha V Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Integrin Alpha V Revenue Market Share by Application (2016-2021)
5.2 Integrin Alpha V Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Integrin Alpha V Revenue by Type (2016-2026)
6.2 North America Integrin Alpha V Revenue by Application (2016-2026)
6.3 North America Integrin Alpha V Market Size by Country
6.3.1 North America Integrin Alpha V Revenue by Country (2016-2026)
6.3.2 United States Integrin Alpha V Market Size and Forecast (2016-2026)
6.3.3 Canada Integrin Alpha V Market Size and Forecast (2016-2026)
6.3.4 Mexico Integrin Alpha V Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Integrin Alpha V Revenue by Type (2016-2026)
7.2 Europe Integrin Alpha V Revenue by Application (2016-2026)
7.3 Europe Integrin Alpha V Market Size by Country
7.3.1 Europe Integrin Alpha V Revenue by Country (2016-2026)
7.3.2 Germany Integrin Alpha V Market Size and Forecast (2016-2026)
7.3.3 France Integrin Alpha V Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Integrin Alpha V Market Size and Forecast (2016-2026)
7.3.5 Russia Integrin Alpha V Market Size and Forecast (2016-2026)
7.3.6 Italy Integrin Alpha V Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Integrin Alpha V Revenue by Type (2016-2026)
8.2 Asia-Pacific Integrin Alpha V Revenue by Application (2016-2026)
8.3 Asia-Pacific Integrin Alpha V Market Size by Region
8.3.1 Asia-Pacific Integrin Alpha V Revenue by Region (2016-2026)
8.3.2 China Integrin Alpha V Market Size and Forecast (2016-2026)
8.3.3 Japan Integrin Alpha V Market Size and Forecast (2016-2026)
8.3.4 South Korea Integrin Alpha V Market Size and Forecast (2016-2026)
8.3.5 India Integrin Alpha V Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Integrin Alpha V Market Size and Forecast (2016-2026)
8.3.7 Australia Integrin Alpha V Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Integrin Alpha V Revenue by Type (2016-2026)
9.2 South America Integrin Alpha V Revenue by Application (2016-2026)
9.3 South America Integrin Alpha V Market Size by Country
9.3.1 South America Integrin Alpha V Revenue by Country (2016-2026)
9.3.2 Brazil Integrin Alpha V Market Size and Forecast (2016-2026)
9.3.3 Argentina Integrin Alpha V Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Integrin Alpha V Revenue by Type (2016-2026)
10.2 Middle East & Africa Integrin Alpha V Revenue by Application (2016-2026)
10.3 Middle East & Africa Integrin Alpha V Market Size by Country
10.3.1 Middle East & Africa Integrin Alpha V Revenue by Country (2016-2026)
10.3.2 Turkey Integrin Alpha V Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Integrin Alpha V Market Size and Forecast (2016-2026)
10.3.4 UAE Integrin Alpha V Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Biogen Inc、BioMAS Ltd、Factor Therapeutics Ltd、MedImmune LLC、Merck & Co Inc、Merck KGaA、Morphic Therapeutic Inc、SciFluor Life Sciences LLC、Vascular Pharmaceuticals Inc
【免責事項】
https://www.globalresearch.jp/disclaimer